M. Rocken et al., IL-4-INDUCED IMMUNE DEVIATION AS ANTIGEN-SPECIFIC THERAPY FOR INFLAMMATORY AUTOIMMUNE-DISEASE, Immunology today, 17(5), 1996, pp. 225-231
Organ-specific autoimmune diseases are mediated by interferon gamma (I
FN-gamma)-producing T helper 1 (Th1) cells. Here, Martin Rocken and co
lleagues review the experimental basis for an antigen-specific therape
utic approach to inflammatory autoimmune diseases. This strategy invol
ves selective deviation of harmful Th1 responses towards an anti-infla
mmatory, interleukin 4 (IL-4)-producing Th2 phenotype.